|
CAS-Nr. | 82586-52-5 |
Bezeichnung: | |
Englisch Name: | MOEXIPRIL HYDROCHLORIDE |
Synonyma: | CI-925;Perdix;Univasc;SPM-925;Fempress;RS-10085;RS-10085-197;MOEXIPRIL HYDROCHLORIDE;Moexipril Hydrochloride (100 mg);(3S)-2-[(2S)-2-[[(1S)-1-carbethoxy-3-phenyl-propyl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid hydrochloride |
CBNumber: | CB6500845 |
Summenformel: | C27H35ClN2O7 |
Molgewicht: | 535.03 |
MOL-Datei: | 82586-52-5.mol |
|
|
|
|
MOEXIPRIL HYDROCHLORIDE physikalisch-chemischer Eigenschaften |
|
MOEXIPRIL HYDROCHLORIDE Chemische Eigenschaften,Einsatz,Produktion Methoden |
Chemische Eigenschaften Crystalline Solid |
|
Verwenden Angiotensin converting enzyme (ACE) inhibitor; dimethoxy analog of quinapril |
|
Verwenden Moexipril HCl is a potent orally active non-sulfhydryl angiotensin converting enzyme inhibitor (ACE) with IC50 of 0.041 μM, which is used for the treatment of hypertension and congestive heart failure |
|
R-Sätze Betriebsanweisung: R50:Sehr giftig für Wasserorganismen. |
|
S-Sätze Betriebsanweisung: S60:Dieses Produkt und sein Behälter sind als gefährlicher Abfall zu entsorgen. |
|
Biologische Aktivit?t Angiotensin-converting enzyme (ACE) inhibitor that is hydrolyzed in the liver to the active metabolite moexiprilat (IC 50 values are 2.1 and 2700 nM for moexiprilat and moexipril respectively). Antihypertensive; decreases mean blood pressure in the spontaneous hypertensive rat (SHR). Also blocks degradation of bradykinin into inactive metabolites. |
|
|
MOEXIPRIL HYDROCHLORIDE Upstream-Materialien And Downstream Produkte |
Upstream-Materialien
|
Downstream Produkte
|
MOEXIPRIL HYDROCHLORIDE Anbieter Lieferant Produzent Hersteller Vertrieb Händler. Global( 56)Lieferanten |
|
|
|
|
MOEXIPRIL HYDROCHLORIDE
82586-52-5
(3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenyl-d5-propyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic Acid Hydrochloride
CI-925
Fempress
Perdix
RS-10085-197
SPM-925
Univasc
(3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic Acid Hydrochloride
Chiral Reagents
C27H35ClN2O7
Intermediates & Fine Chemicals
Pharmaceuticals
C27H35N2O7Cl
C27H34N2O7HCl
(3S)-2-[(2S)-2-[[(1S)-1-carbethoxy-3-phenyl-propyl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid hydrochloride
(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenyl-butan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid hydrochloride
(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid hydrochloride
2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylicacidhydrochloride
Aromatics
Inhibitors
API
3-Isoquinolinecarboxylicacid,2-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]aMino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-diMethoxy-,hydrochloride (1:1), (3S)-
(3S)- 2-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid,hydrochloride (1:1)
RS-10085
Moexipril Hydrochloride (100 mg)
|